Pharmacologic Management of Myofascial Pain

Huang-Lionnet, Julie H.; Hameed, Haroon; Cohen, Steven P.

doi:10.1016/b978-0-323-40196-8.00053-x

Cited by 6 publications

(11 citation statements)

References 95 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Structurally similar to cyclobenzaprine are tricyclic antidepressants (TCAs). At a relatively low dose compared to treating depression, TCAs have been shown to be effective in reducing the frequency and intensity of pain arising from TMD; however, the numerous detrimental effects that ensue, notably dry mouth, fluid retention and cardiotoxicity, have limited its routine use [ 50 ]. Another potent class of central-acting drugs are opioids; however, their use has been discouraged to minimize central nervous system depression and physical dependence [ 51 ].…”

Section: Treatment Modalitiesmentioning

confidence: 99%

Diagnosis and Treatment of Myogenous Temporomandibular Disorders: A Clinical Update

Chan

et al. 2022

Diagnostics

View full text Add to dashboard Cite

Myogenous temporomandibular disorders (M-TMDs) are the most common chronic orofacial pain, affecting the masticatory muscles and, thus, jaw movement. While a concise diagnosis is crucial to formulate a rational treatment plan, the similarities in clinical presentations that M-TMDs share with other neuromuscular disorders affecting the temporomandibular joint (TMJ) could easily confuse physicians. In addition to the basics, such as thorough history taking and meticulous clinical examinations, different imaging techniques are useful adjuncts to facilitate the diagnostic process. This review presents an overview of the current understanding on a variety of diagnostic and treatment modalities for M-TMD patients. It is essential to highlight that there is not a single treatment for all, and the benefits of multidisciplinary strategies have been noted for the effective management of myogenous TMD pain. Treatment modalities ranging from conservative to minimally invasive options are discussed in this review.

show abstract

Section: Treatment Modalitiesmentioning

confidence: 99%

Diagnosis and Treatment of Myogenous Temporomandibular Disorders: A Clinical Update

Chan

et al. 2022

Diagnostics

View full text Add to dashboard Cite

show abstract

“…Additionally, pregabalin has been indicated as a first-line treatment option for fibromyalgia. Unfortunately, in relation to MPS, the research is lacking, with only weak evidence to support the use of gabapentinoids in this condition 9,14…”

Section: Treatment Optionsmentioning

confidence: 99%

“…Palpation of an active trigger point typically reproduces the patient's symptoms, whereas latent trigger points may not be noted by the patient until direct palpation, although they still contribute to decreased range of motion and stiffness of the affected muscle 7. Some studies estimate that latent MTrPs are present in the shoulder muscles of about half of asymptomatic young adults and in lumbogluteal muscles in up to 45% 9. The most commonly cited etiologies for MPS and MTrPs are trauma, overuse, repetitive microtrauma, and joint dysfunction 3.…”

mentioning

confidence: 99%

An overview of myofascial pain syndrome with a focus on trigger point injection

Bodine

2023

The Nurse Practitioner

View full text Add to dashboard Cite

Myofascial pain syndrome (MPS) is a very common condition, with an estimated lifetime prevalence of 85% in the general population. MPS is commonly underdiagnosed or misdiagnosed due to the lack of standardized diagnostic criteria and the symptoms' overlap with those of other musculoskeletal pain conditions. The most notable and bothersome feature of MPS is the presence of myofascial trigger points (MTrPs), hypersensitive areas of muscle commonly characterized as knots, nodules, or bumps that cause strain and pain with and oftentimes without stimulation. A low-risk, low-cost procedure, trigger point injection (TPI) is the gold standard for MPS treatment, and NPs can perform the procedure in an outpatient practice setting. Through administration of TPIs and use of other treatment modalities, primary care NPs can significantly impact the quality of life for those patients affected by acute and chronic MPS. This article aims to educate primary care NPs on MPS diagnosis and provide an overview of treatment options, with a focus on TPI use and administration for MPS relief.

show abstract

“…Diazepam: Cause respiratory depression, hypotension, drowsiness, dizziness, muscle weakness, headache, dry mouth, constipation, ataxia (loss of control of body movement), somnolence, confusion. [55][56][57] Phenobarbital: Cause behavioral problems, hyperactivity, sedation is major side effect, dementia, loss of appetite, tiredness, dizziness, drowsiness. 58,59 Phenytoin: Causesedation, psychosis, hyperkinesias, megaloblastic anemia, decreased serum folate degree, gingival hyperplasia (overgrowth of the gums), IGA deficiency, lowered bone mineral composition, liver disease, acne, hirsutism (excessive hair on the face/ body/overgrowth of hair ), coarseness of facial features, unsteady or shaky, atrophy of cerebellum, cause ataxia and nystagmus, gingival hypertrophy perhapscharacterized to changed collagen metabolism.…”

Section: Common Side Effects Of Some Anti-epileptics Medicationsmentioning

confidence: 99%

Ilae classification of seizures and antiepileptic medications apothegmatic: hereafter advancement and clinical practice

Bereda¹

2022

JPCPY

View full text Add to dashboard Cite

Introduction: The Antiepileptic medications are frequently categorized into divisions such as ‘first-generation’ (i.e., carbamazepine, phenobarbital, phenytoin, primidone, and valproate) and ‘second-generation’ (lamotrigine, levetiracetam, felbamate, gabapentin, topiramate, tiagabine, oxycarbazepine, zonisamide, and pregabalin). Chronic phenytoin ingestion leads to its impact in the cerebral cortex, resulting in atrophy of cerebellum, cause ataxia and nystagmus. Objective: To recapitulate the International league against epilepsy classifications, first treatment for epilepsy based on their classifications, antiepileptic medications adverse drug reaction, Methodology: The author used 74 distinctive published articles for the accomplishment of this review article. Google search engine was used for accessing published articles from databases like Google Scholar, Research Gate, PubMed, NCBI, NDSS, PMID, PMCID, Cochrane Database and CLINMED international library. Findings: Tonic-clonic is characterized by stiffness for loss of consciousness occurred by tonic extension and rhythmic clonic contractions of all considerable muscle groups. Antiepileptic drugs are implicitly an effective treatment for patient with epilepsy. Carbamazepine cause serious and sometimes fatal dermatologic reactions, including toxic epidermal necrolysis and stevens-johnson syndrome, aplastic anemia and agranulocytosis, Suicidal Behavior and Ideation, Stevens johnson syndrome, cholestatic jaundice, ataxia, xerostomia, speech disturbances, feeling sleepy Conclusion: Commonly happening side-effects of AEDs are memory troubles, exhaustion, tremors, gastrointestinal symptoms, osteoporosis, depression, drowsiness, dizziness, weight change, nausea. In generalized seizures, on the other hand, the seizure is generalized from the endeavor (i.e., primary generalized seizures), launching in both hemispheres of the brain contemporaneously

show abstract

Pharmacologic Management of Myofascial Pain

Cited by 6 publications

References 95 publications

Diagnosis and Treatment of Myogenous Temporomandibular Disorders: A Clinical Update

Diagnosis and Treatment of Myogenous Temporomandibular Disorders: A Clinical Update

An overview of myofascial pain syndrome with a focus on trigger point injection

Ilae classification of seizures and antiepileptic medications apothegmatic: hereafter advancement and clinical practice

Contact Info

Product

Resources

About